A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label

National Taiwan University Hospital, Taipei

Chang Gung Medical Foundation, Taoyuan

Chris O'Brien Lifehouse, Camperdown

Concord Repatriation General Hospital, Concord

North Coast Cancer Institute, Coffs Harbour

Eastern Health, Box Hill

Frankston Hospital, Frankston

Ballarat Oncology and Haematology, Wendouree

Princess Alexandra Hospital, Wolloongabba

Icon Cancer Care, Southport

Townsville Hospital, Douglas

Flinders Medical Centre, Bedford Park

Taipei Veterans General Hospital, Taipei

Queens Hospital Cancer Center, Jamaica

Taipei Medical University, Taipei

UPMC Cancer Center Cancer, Pittsburgh

IRCCS Istituto Clinico Humanitas, Rozzano MI

IRCCS Ospedale S.Raffaele, Milan

Ospedale Treviglio-Caravaggio, Treviglio BG

Istituti Ospitalieri di Cremona - Oncologia, Cremona

Fondazione Salvatore Maugeri, Pavia

University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, Deerfield Beach

Boca Raton Regional Hospital Lynn Cancer Institute, Boca Raton

Policlinico S.Orsola Malpighi, Bologna

Chung Shan Medical University, Taichung

China Medical University Hospital, Taichung

Aultman Hospital, Canton

Gabrail Cancer Center, Canton

U.O.C. Oncologia, Lucca

Mayo Clinic, Rochester

National Cheng Kung University, Tainan City

Cancer Center of Acadiana, Lafayette

AO G.Rummo, Benevento

Huntsman Cancer Institute, Salt Lake City

Torrance Memorial Medical Center, Redondo Beach

UCSF Fresno, Fresno

Kaiser Permanente Hawaii, Honolulu

Korea University Guro Hospital, Guro-gu

National Cancer Centre, Singapore

John Hopkins Singapore International Medical Center, Central Singapore

Valley Medical Group, Paramus

Tuen Mun Hospital, Tuenmen

Queen Mary Hospital, Pok Fu Lam

Chungbuk National University Hospital, Chungcheongbuk-do

Chonnam National University Hwasun Hospital, Jeonnam

Severance Hospital, Yonsei Uni, Seoul

Samsung Medical Center, Seoul